WallStreetZenWallStreetZen

NASDAQ: TSVT
2seventy Bio Inc Stock Ownership - Who owns 2seventy Bio?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have 2seventy Bio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Casdin Capital LLCDirector2024-03-2640,000$5.10
$204.00kBuy
Casdin Capital LLCDirector2024-03-25330,000$5.07
$1.67MBuy
Casdin Capital LLCDirector2024-03-22147,377$5.12
$754.13kBuy
Casdin Capital LLCDirector2024-03-21300,000$4.90
$1.47MBuy
Nick LeschlyPresident and CEO2024-01-051,554$3.75
$5.83kSell
William D. Baird IiiChief Operating Officer2024-01-051,380$3.75
$5.18kSell
Philip D. GregoryChief Scientific Officer2024-01-05795$3.75
$2.98kSell
William D. Baird IiiChief Operating Officer2024-01-0333,651$3.87
$130.20kSell
Nick LeschlyPresident and CEO2024-01-0372,312$3.87
$279.78kSell
Philip D. GregoryChief Scientific Officer2024-01-0325,613$3.87
$99.10kSell

1 of 3

TSVT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TSVT insiders and whales buy or sell their stock.

TSVT Shareholders

What type of owners hold 2seventy Bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Kynam Capital Management LP19.71%10,111,394$49.14MInsider
Kynam Global Healthcare Master Fund LP19.71%10,111,394$49.14MInsider
Kynam Capital Management LP11.60%5,953,825$28.94MInstitution
Morgan Stanley9.44%4,842,810$23.54MInstitution
Goldman Sachs Group Inc8.79%4,508,800$21.91MInstitution
Vanguard Group Inc7.77%3,985,770$19.37MInstitution
Blackrock Inc7.62%3,911,724$19.01MInstitution
Casdin Capital LLC6.23%3,199,223$15.55MInsider
Baker Bros Advisors LP4.87%2,497,526$12.14MInstitution
Millennium Management LLC4.55%2,335,272$11.35MInstitution

1 of 3

TSVT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSVT65.20%34.80%Net BuyingNet Buying
VTYX39.06%60.94%Net SellingNet Selling
INO61.56%38.44%Net SellingNet Selling
AEON22.93%61.40%Net Selling
FENC4.18%95.82%Net BuyingNet Selling
View Top Biotech Stocks

2seventy Bio Stock Ownership FAQ

Who owns 2seventy Bio?

2seventy Bio (NASDAQ: TSVT) is owned by 93.92% institutional shareholders, 50.12% 2seventy Bio insiders, and 0.00% retail investors. Kynam Capital Management LP is the largest individual 2seventy Bio shareholder, owning 10.11M shares representing 19.71% of the company. Kynam Capital Management LP's 2seventy Bio shares are currently valued at $51.16M.

If you're new to stock investing, here's how to buy 2seventy Bio stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.